Sharps Technology Reports Over 2 Million SOL Tokens in Treasury
Sharps Technology’s Q3 2025 results reveal a $103 million net loss, medical device sales, and a sharp drop in Solana holdings’ valuation amid digital asset market volatility.
SOL
Fact Check
The assessment is based on a strong consensus across multiple credible sources directly reporting on Sharps Technology's official financial statements. Several sources explicitly confirm the claim. A news report on the company's Q3 2025 financial results directly states, 'The company's treasury now holds over 2 million SOL.' This is corroborated by two separate news flashes from a crypto media outlet and a report from Stock Titan, which also confirm a holding of 'over 2 million SOL' or a '2M SOL Treasury' based on the same financial report. Furthermore, a report from the reputable crypto research firm Messari notes a partnership where Sharps Technology staked '2 million SOL,' strongly supporting the scale of their holdings. While some sources are less specific, mentioning a 'Solana Buyback' or not providing a number, no source contradicts the claim. The evidence is consistent, direct, and originates from reports on the company's official financial disclosures, making the statement highly likely to be true.
Summary
Sharps Technology posted a $103 million net loss for Q3 2025, with core medical device revenue totaling $83,622. The company held approximately 2 million Solana (SOL) tokens in its treasury, valued at $404 million as of September 30. By current market prices, the holdings’ value dropped to $275 million, reflecting substantial volatility in digital asset markets.
Terms & Concepts
- Solana (SOL): A high-performance blockchain supporting decentralized applications with fast transactions and low fees.
- Staking: Locking cryptocurrency in a blockchain network to support operations and earn rewards.
- PIPE Financing: Private Investment in Public Equity, a funding arrangement where investors purchase stock directly from a public company at a set price.